Gnosis by Lesaffre
137 rue Gabriel Péri
+33 (0)3 20 81 61 00
10 Nov 2022 --- Mushroom ingredient innovators Scelta Inside and MBio have signed a distribution agreement allowing the two companies to cooperate in bringing vitamins derived from the... Read More
FOOD INGREDIENTS NEWS
01 Nov 2022 --- PLT Health Solutions has received approval from the Non-GMO Project to sell its menatto brought by Japanese oils producer J-Oil Mills under this label. Menatto is a vitamin made... Read More
14 Oct 2022 --- This week in industry news, Gnosis picked up a new ingredient award from the Nutrition Industry Executive (NIE). Also, Advanced Container Technologies announced a sustainable... Read More
NUTRITION & HEALTH NEWS
29 Sep 2022 --- Ahead of Gnosis by Lesaffre’s webinar on October 11 (15:00 CEST), which will focus on Quatrefolic as a supplement and the importance of innovating in the field.... Read More
NUTRITION & HEALTH NEWS
22 Sep 2022 --- Immunity has been a concern for consumers and the COVID-19 pandemic exacerbated anxieties, pushing the nutrition space forward. Innova Market Insights has reported that, globally,... Read More
02 Sep 2022 --- Immunity continues to dominate market demands across supplements, however the space has also seen broadening opportunities for formulations supporting mood, cognition, stress and prebiotics. Seeking to offer a new range of opportunities, Gnosis by Lesaffre is exploring different ideas for new applications for its existing solutions such as its vitaMK7. NutritionInsight speaks to Marc Philouze on the company’s vitamin K2 reformulation, which makes it more stable when synergizing with different ingredients.
18 Jul 2022 --- This innovative prebiotic promotes a balanced gut microbiota and induces a metabolic dependant-response on the host enterotype. Last but not least, a low dosage is enough to enhance the microbiota diversity for better immune activities!Thanks to this adaptive improvement of different microbiota profiles composition, Lynside® Immunity Prebiotic offers untapped opportunities in personalized and adapted micronutrition.
15 Feb 2022 --- Following the acquisition of Nattopharma, Gnosis by Lesaffre’s managing director Marc Philouze details the company’s approach to further expansion. Innovation is a key priority, which means companies that can offer new ingredients or products are especially appealing as partners.
29 Jun 2021 --- Following Lesaffre’s recent microbiota online seminar, Sophie Legrain-Raspaud, research and application director for Gnosis by Lesaffre, shares how the microbiota field reaches beyond human health research to animal, plant and fermentation studies. Her colleague Hassina Ait-Abderrahim, director of in vitro and bacteria platforms, also details Lesaffre’s latest emerging technologies and upcoming research.
08 Dec 2020 --- Julie Lemahieu is the market manager of wellness and immune health at Gnosis by Lesaffre, the makers of LifeinU BSCU1, a stable probiotic for immune support. She explains that while immunity is not a new demand, 2020 saw particularly strong demand. Other themes include naturality as some consumers look for alternative ways to maintain their health. The company is also set to soon launch a “disruptive” nutritional yeast.
21 Mar 2022 --- The latest edition of Quatrefolic® 360° collection is out! In 2019, the World Health Organization estimated that one third of global deaths were caused by cardiovascular events. In this new issue of Quatrefolic® 360°, you will learn more about the likely correlation between the active folate 5-MTHF supplementation and cardiovascular health.
28 Feb 2022 --- Gnosis by Lesaffre is giving the market an innovation with Lynside® Immunity Prebiotic: the first patented prebiotic yeast cell wall. Its proven prebiotic effect in different human enterotypes is supported by a dynamic in-vitro gut-model study. Lynside® Immunity Prebiotic allows specific bacteria to thrive and promote different immune activities.
01 Nov 2021 --- Newly recognized for supporting bone and cardiovascular health, Vitamin K2's mechanism of action is now identified as impacting other health areas, including brain health, healthy joints, vision health, and more. All of this lends itself to the argument that correcting a widespread K2 deficiency can significantly impact global health.
THE WORLD OF FOOD INGREDIENTS
10 Dec 2015 --- Lesaffre is strengthening its presence in the nutritional ingredients fermentation and human health sector. It recently acquired Gnosis, an Italian company specialized in the development, production and sale of fermentation ingredients for the pharma, nutraceutical, cosmetic and veterinary industries.
12 Oct 2022 --- Folate status is a crucial aspect of women's health at reproductive age, but not only …Is the industry aware of the market opportunities that the proper folate offers?In the webinar, you learn about:Why the folate market is so trendyHow Quatrefolic® differs from other forms of folate, like folic acidFolate metabolism in methylationFolate role in supporting pregnancy and fertility, and other factors that can reduce/increase the risk of folate deficiency
09 Dec 2021 --- Folate, also known as vitamin B9, is well known for being a mandatory supplement during pregnancy. However, the knowledge of its different forms and benefits may still raise some questions. Gnosis by Lesaffre illustrates the main differences between the two forms of vitamin B9, focusing on the characteristics of Quatrefolic, the active form of folate.This is the question that Professor Luca Tiano will try to answer together with Silvia Pisoni, Global Marketing Manager of Gnosis by Lesaffre, and Blandine Clay, Product Manager.During the webinar, they will illustrate the main differences between the two forms of vitamin B9, focusing on the characteristics of Quatrefolic, the active form of folate. The presentation will focus on its actions on polymorphic metabolisms and the many benefits and claims that Quatrefolic provides for all folate needs.